...“LX6171 may have potential in a broad range of applications involving cognitive disorders, including Alzheimer’s disease, attention disorders, and developmental disorders.”... Lexicon Pharmaceuticals' Press Release -
Showing posts with label Lexicon Pharmaceuticals. Show all posts
Showing posts with label Lexicon Pharmaceuticals. Show all posts
Friday, April 25, 2008
Lexicon : Clinical Data for LX6171, a Drug Candidate for Cognitive Disorders
...“LX6171 may have potential in a broad range of applications involving cognitive disorders, including Alzheimer’s disease, attention disorders, and developmental disorders.”... Lexicon Pharmaceuticals' Press Release -
Subscribe to:
Posts (Atom)